Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer - Lorenzo Castagnoli; Alma Franceschini; Valeria Cancila; Matteo Dugo; Martina Bigliardi; Claudia Chiodoni; Paolo Toneguzzo; Viola Regondi; Paola A. Corsetto; Filippo Pietrantonio; Serena Mazzucchelli; Fabio Corsi; et al. (Journal of Experimental & Clinical Cancer Research)